| |
| |
|
| Insider
Information: |
Skvarka Jan |
| Relationship: |
Director |
| City: |
Mississauga |
| State: |
A6 |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
47,970 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
47,970 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Trillium Therapeutics Inc |
TRIL |
President and CEO, Dir... |
2021-05-12 |
0 |
2021-01-13 |
0 |
Premium* |
|
|
Zentalis Pharmaceuticals, Llc |
ZNTL |
Director |
2023-09-11 |
47,970 |
2022-09-09 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2023-09-11 |
4 |
AS |
$25.05 |
$125,238 |
D/D |
(5,000) |
47,970 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2023-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
16,364 |
52,970 |
0 |
- |
|
| ZNTL |
Zentalis Pharmaceuticals,... |
Director |
– • – |
2022-09-09 |
4 |
A |
$0.00 |
$0 |
D/D |
36,606 |
36,606 |
0 |
- |
|
| TRIL |
Trillium Therapeutics Inc |
President and CEO |
• • – |
2021-05-12 |
4 |
S |
$9.24 |
$219,880 |
D/D |
(23,802) |
0 |
0 |
% |
|
| TRIL |
Trillium Therapeutics Inc |
President and CEO |
• • – |
2021-05-12 |
4 |
OE |
$0.31 |
$7,474 |
D/D |
23,802 |
23,802 |
0 |
- |
|
| TRIL |
Trillium Therapeutics Inc |
President and CEO |
• • – |
2021-05-11 |
4 |
S |
$9.20 |
$981,803 |
D/D |
(106,698) |
0 |
0 |
% |
|
| TRIL |
Trillium Therapeutics Inc |
President and CEO |
• • – |
2021-05-11 |
4 |
OE |
$0.31 |
$45,071 |
D/D |
106,698 |
106,698 |
0 |
- |
|
| TRIL |
Trillium Therapeutics Inc |
President and CEO |
• • – |
2021-01-14 |
4 |
AS |
$15.03 |
$294,279 |
D/D |
(19,581) |
0 |
0 |
% |
|
| TRIL |
Trillium Therapeutics Inc |
President and CEO |
• • – |
2021-01-14 |
4 |
OE |
$0.43 |
$8,371 |
D/D |
19,581 |
19,581 |
0 |
- |
|
| TRIL |
Trillium Therapeutics Inc |
President and CEO |
• • – |
2021-01-13 |
4 |
AS |
$15.04 |
$81,508 |
D/D |
(5,419) |
0 |
0 |
% |
|
| TRIL |
Trillium Therapeutics Inc |
President and CEO |
• • – |
2021-01-13 |
4 |
OE |
$0.42 |
$2,302 |
D/D |
5,419 |
5,419 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
